An NCI-designated Comprehensive Cancer Center

Mina S. Sedrak, M.D., M.S.

Medical Oncologist
Clinical Expertise
  • Breast Oncology
  • Geriatric Oncology
Research Focus
  • Breast Cancer and Aging Research
  • Clinical and Biological Predictors of Chemotherapy Toxicity in Older Women with Early-stage, High-risk Breast Cancer
  • Therapeutic Clinical Trials for Older and Frail Patients with Breast Cancer
  • Barriers to Inclusion of Older Adults in Breast Cancer Clinical Trials
  • Social Media and Digital Health
Assistant Professor, Department of Medical Oncology & Therapeutics Research
Other Languages Spoken
  • Arabic

Clinical Teams

Mina S. Sedrak, M.D., M.S., is an assistant professor in the Department of Medical Oncology and Therapeutics Research.
Dr. Sedrak is a clinically trained medical oncologist specializing in the care of older adults with breast cancer. The mission of his research program is to improve the health and well-being of older patients with breast cancer. His research interests and ongoing projects include identifying clinical and biological factors that predict the risk of chemotherapy toxicity in older women with early-stage breast cancer, investigating alternate treatment regimen for frail older patients, and improving cancer clinical trial participation of older adults. His training and experience includes analysis of large secondary databases, survey development and qualitative methods, and design of therapeutic clinical trials for older and/or frail adults with cancer, capturing endpoints that are pertinent to this population such as preservation of function, cognition and independence.
Dr. Sedrak is the recipient of several intramural and extramural grants, including an NIH K12 career development award, that support his work at the interface of breast cancer and aging. He serves as co-chair of the Junior Faculty Advisory Board of the “Cancer and Aging Research Infrastructure Grant” (R21/R33 AG059206), co-chair of the Junior Cancer and Aging Research Group, and co-chair of the Breast Cancer Working Group in the Alliance Cancer in the Older Adult Committee. Additionally, Dr. Sedrak serves on the National Cancer Institute’s Diversifying Accrual Working Group, bringing expertise as a geriatric oncology researcher and informing methods of improving the accrual of older adults with cancer. He is also an appointed member of the ASCO Scientific Program Committee and serves on the Cancer.Net Editorial Board’s geriatric oncology advisory panel.
Dr. Sedrak earned his undergraduate degree in biological sciences from University of Chicago. He received his medical doctorate from Rush Medical College, where he was inducted into the Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in hematology/oncology at the University of Pennsylvania, where he also received a Master of Science in Health Policy Research.


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

  • Sedrak MS, Dizon DS, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim JC, Miller RS, Thompson MA, Utengen A, Attai DJ. The Emerging Role of Professional Social Media Use in Oncology. Future Oncology. 2017: Published online June 7. PMID: 28589770.
  • Sedrak MS, Myers JS, Small DS, Nachamkin I, Ziemba JB, Murray D, Kurtzman GW, Zhu J, Wang W, Mincarelli D, Danoski D, Wells BP, Berns JS, Brennan PJ, Hanson CW, Dine CJ, Patel MS.  Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial. JAMA Internal Medicine. 2017.
  • Sedrak MS, Patel MS, Ziemba JB, Murray D, Kim EJ, Dine CJ, Myers JS. Residents’ Self-report on Why They Order Perceived Unnecessary Inpatient Laboratory Tests. Journal of Hospital Medicine. Aug 2016. [Epub ahead of print]. PMID: 27520384.
  • Attai DJ, Sedrak MS*, Katz MS, Thomspon MA, Anderson PF, Kesselheim JC, Fisch MJ, Graham DL, Utengen A, Johnston C, Miller RS, Dizon DS. Social Media in Cancer Care: Highlights, Challenges and Opportunities. Future Oncology. 12(13):1549-52, Jul 2016. PMID: 27025657. [*Co-first author]
  • Sedrak MS, Cohen RB, Merchant RM, Schapira MM. Cancer Communication in the Social Media Age. JAMA Oncology. 1;2(6):822-3, Jun 2016. PMID: 26940041.
  • Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case-Control Study. Clinical Gastroenterology and Hepatology. 11(12): 1601-8, Dec 2013. PMID: 23872237.
  • Barbieri JS, Seshasai R, Shemesh A, Sedrak MS, Hoffman B, Alley EW. Thymic Neuroendocrine Tumor Presenting with the Ectopic ACTH Syndrome. Journal of Thoracic Oncology. 8(6): e57-8, Jun 2013. PMID: 23676563.

Complete list of published work

In The News